GSA Capital Partners LLP Acquires Shares of 10,959 CorVel Corp. $CRVL

GSA Capital Partners LLP acquired a new position in CorVel Corp. (NASDAQ:CRVL) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,959 shares of the business services provider’s stock, valued at approximately $685,000.

Other hedge funds have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. purchased a new position in shares of CorVel in the third quarter valued at $31,000. Los Angeles Capital Management LLC bought a new position in shares of CorVel in the fourth quarter worth approximately $33,000. Rockefeller Capital Management L.P. increased its holdings in shares of CorVel by 66.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock worth $39,000 after buying an additional 230 shares during the last quarter. Quarry LP increased its stake in CorVel by 218.6% in the third quarter. Quarry LP now owns 513 shares of the business services provider’s stock valued at $40,000 after acquiring an additional 352 shares during the last quarter. Finally, Torren Management LLC purchased a new position in shares of CorVel during the fourth quarter worth approximately $46,000. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CRVL. Weiss Ratings raised shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, CorVel presently has a consensus rating of “Hold”.

Insider Buying and Selling at CorVel

In other CorVel news, insider Maxim Shishin sold 2,250 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $60.59, for a total value of $136,327.50. Following the transaction, the insider directly owned 7,050 shares in the company, valued at approximately $427,159.50. This trade represents a 24.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey J. Michael sold 9,000 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $60.98, for a total value of $548,820.00. Following the completion of the transaction, the director directly owned 559,721 shares in the company, valued at approximately $34,131,786.58. This represents a 1.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 13,249 shares of company stock valued at $807,126. Insiders own 39.72% of the company’s stock.

CorVel Trading Up 5.1%

CorVel stock opened at $70.78 on Thursday. CorVel Corp. has a 12 month low of $44.83 and a 12 month high of $93.71. The stock has a fifty day simple moving average of $61.89 and a two-hundred day simple moving average of $57.55. The firm has a market cap of $3.61 billion, a price-to-earnings ratio of 31.46 and a beta of 0.98.

CorVel (NASDAQ:CRVL) last posted its earnings results on Tuesday, August 4th. The business services provider reported $0.63 earnings per share (EPS) for the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%. The business had revenue of $259.93 million for the quarter.

CorVel Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).